Print Page   |   Contact Us   |   Sign In   |   Join ISBER
Biospecimen Research Symposium - Speakers
Share |
 Morten Allentoft, PhD 
  Morten Allentoft is a danish evolutionary biologist specialising in ancient DNA research. He has an MSc in population genetics from the University of Copenhagen (2007) studying genetics of endangered amphibians. Moving to New Zealand for his PhD, he worked on ancient DNA from extinct megafauna and continued this work in a 2010-2011 post doc at Murdoch University in Perth. In 2011 he returned to Copenhagen switching focus to another fascinating species, namely Homo sapiens. Funded by the Villum Foundation (Young Investigator Programme), MA is currently employed as an assistant professor at the Natural History Museum in Copenhagen. Among many things, he is involved in several large-scale ancient genomics projects that aim to understand early human migration and dispersal patterns.
 Jonas Astrin, MSc, MA, PhD 
Jonas Astrin is curator of the biobank and head of the DNA barcoding unit at the Zoological Museum Alexander Koenig (ZFMK), Germany. He was trained as a zoologist at the universities Würzburg, Bonn, and UT Austin (TX) and as a scientific librarian at the Humboldt University Berlin. Merging these two specializations brought him to animal biobanking. Jonas is active in the biobanking networks GGBN, ISBER, ESBB, and Frozen Ark.
 Glenn Begley, MBBS, PhD, FRACP, FAHMS 
Dr. Begley is inaugural CEO of BioCurate, an initiative of Monash and Melbourne Universities to provide commercial focus for drug development. He served previously as CSO of two companies in the USA, and was vice-president of hematology/oncology research at Amgen. There he highlighted the issue of research integrity. Before Amgen he had over 20 years of clinical experience in medical oncology. His personal research focused on regulation of hematopoietic cells and translational clinical trials. His early studies first described human G-CSF, and later clinical studies demonstrated that G-CSF-"mobilized" blood stem cells hastened hematopoietic recovery, a finding that revolutionized bone-marrow transplantation. 
 Daniel Chelsky, PhD 
Dr. Chelsky is the CSO at Caprion Biosciences, a company using mass spectrometry to identify and quantify proteins of interest for biomarker discovery and validation, as well as mechanism of action and microbiome research. Previously he served as president of BioSignal, a subsidiary of PerkinElmer focused on GPCR-related research and reagents. He has also held positions as senior director of biology at Pharmacopeia, a combinatorial chemistry company, director of drug discovery at Onyx Pharmaceuticals, and principal investigator at DuPont Merck Pharmaceuticals. He received his PhD at the University of Oregon and was an American Cancer Society fellow at UC Berkeley. 
 Carolyn Compton, MD, PhD 
Carolyn Compton, MD, PhD, is a pathologist, professor of life sciences at Arizona State University and professor of pathology at the Johns Hopkins Medical School. She is the chief medical officer of the National Biomarkers Development Alliance and the Complex Adaptive Systems Institute. Formerly, she was professor of pathology at Harvard Medical School and the Strathcona professor at McGill. More recently she was the director of the Office of Biorepositories and Biospecimen Research at the US National Cancer Institute and recipient of the ISBER Award for Outstanding Achievement in Biobanking. She has authored more than 500 academic publications. 
 Peter Findeisen, MD 
*More information will be available shortly.
 Steven Groot, PhD 
Steven Groot has worked for over 25 years with plant seeds quality. One of his main topics is improving the storability of seeds. Most seeds are desiccation tolerant, meaning they can be stored under dry conditions, nevertheless they still slowly deteriorate during storage. Traditionally seeds are stored at low moisture levels and temperatures to delay aging. His team has shown that anoxia storage is a third and powerful condition to reduce the rate of seed deterioration. On the other side they have developed a test under elevated oxygen pressure to study genetic variation in seed longevity under dry conditions. 
 Stephen Hewitt, MD, PhD 

Stephen M. Hewitt, MD, PhD, is a clinical investigator within the laboratory of pathology, National Cancer Institute and serves as head of the Experimental Pathology Laboratory. Stephen received his BA from the Johns Hopkins University, and his MD and PhD degrees from the University of Texas Health Science Center, Houston. He completed his residency in anatomic pathology at the NCI. Dr. Hewitt is editor-in-chief of the Journal of Histochemistry & Cytochemistry. Dr Hewitt has co-authored over 270 articles and servers on the editorial board of four peer-reviewed journals. 
 Michael Kiehntopf 
*More information will be available shortly.
 Sabine Lehman 
*More information will be available shortly.
 Keith Manger 
   *More information will be available shortly.
 William Mathieson, PhD 
*More information will be available shortly.
 Sean May, PhD 
Professor Sean May has been director of the Nottingham Arabidopsis Stock Centre (NASC: http://arabidopsis.info/) since 1999. His 1991 D.Phil addressed evolutionary developmental neurogenetics, leading to postdoctoral work on Drosophila, and then up the evolutionary scale to research on plants (and Arabidopsis in particular). Sean actively promotes standards, controlled vocabularies and ontologies, particularly with reference to post-genomic and phenotypic data. NASC sends out more than 100,000 tubes of seed annually to researchers all over the world and runs on a mixed economy of grants and cost-recovery. 
 Helen Moore, PhD  
Dr. Helen Moore leads the National Cancer Institute’s Biorepositories and Biospecimen Research Branch (BBRB). As chief she sets the direction and strategic vision for the Branch and oversees several projects related to biobanking, including: the NCI best practices for biospecimen resources, a foundational document for biobanking in use internationally; a biospecimen science research program to develop the evidence for biospecimen best practices; the Biospecimen Research Database, a web-based biospecimen science literature database; research in the ethical, legal, and social implications of biobanking; and biobanking operations for major NCI and NIH programs including the NIH Genotype-Tissue Expression (GTEx) project. 
 Philip Norris, MD 
Philip Norris, MD, is the VP of Research and Scientific Programs at Blood Systems Inc., and Director of Laboratory Sciences-SF for Blood Systems Research Institute (BSRI), a UCSF-affiliated research institute. He is also an Adjunct Professor of Laboratory Medicine and Clinical Professor of Medicine at the University of California, San Francisco. The Norris lab research interests focus on how the human immune system responds to viral infections and transfusion. 
 Uwe Oelmueller 
At QIAGEN, Dr. Oelmueller heads the MDx Technology Center for Sample Technologies. At the QIAGEN / BD joint venture company PreAnalytiX he is QIAGEN’s management committee co-chair. Dr. Oelmueller was the coordinator of the EU FP7 Collaborative Grant Project SPIDIA (2008 – 2013) and is the current coordinator of the EU Horizon 2020 Coordination and Support Action SPDIA4P (2017 – 2020). He is convener of the ISO/TC 212 WG 4 and deputy convener of the CEN/TC 140 WG 3. In 2017 he received the “DIN Honorary Needle” Award for his international engagement in standards developments for quality management in medical laboratories. 
 Johan Paulsson, PhD 
Johan Paulsson's area of expertise is cell biology and pharmacology and he works at Novo Nordisk A/S with early stage R&D in an in vitro biology department. In projects, he characterizes protein and peptide analogues for their ability to bind to and activate their cellular receptors and to gain understanding of the biological mode of action of new entities within obesity and diabetes research.
 Elmar Schilling, PhD 

Dr. Schilling joined Eurofins Genomics in 2010 and is currently leading a team for next generation sequencing (NGS). He has studied molecular biology and completed his PhD studies at the Regensburg University Medical Center (Germany) in 2009. Between 2004 and 2005 he spend several months as a visiting scientist at the University of Chapel Hill (UNC, North Carolina, USA). During his research, Dr. Schilling worked in the field of oncology and hematology focusing on epigenetics and gene regulation. His team at Eurofins is responsible for the routine production, for the implementation of new protocols/workflows and for quality assurance tasks.
 Thomas Schlange, PhD 
Thomas Schlange received his Diploma in Chemistry in 1998 and his PhD in 2003 at the TU Braunschweig, Germany, focussing on early cardiac development. From 2003 until 2008 he worked as a postdoctoral fellow at the Friedrich Miescher Institute in Basel, Switzerland, on Wnt and EGFR signalling in breast cancer. Since 2008 Thomas Schlange is scientist with Bayer AG in Wuppertal, Germany, and is responsible for biomarker projects/strategy in lung indications. Since 2015 he is the EFPIA coordinator of the Innovative Medicines Initiative consortium CANCER-ID on circulating tumor cell, circulating free tumor DNA and miRNA technology evaluation. 
 Katheryn Shea, BS 
  Kathi Shea is the Biobanking Business Lead for Brooks Life Sciences. She is a former President of the International Society for Biological and Environmental Repositories (ISBER) and an active member of several ISBER committees and working groups. Kathi served on the Advisory Working Group that developed the College of American Pathologists Biorepository Accreditation Program and is an active member of the CAP BAP Committee. She has over 25 years of experience leading biorepository programs and advising on the design of biorepositories, quality systems, and optimal methods for collection, preservation and annotation of biological sample collections. 
 Andreas Spittler, MD, PhD 
Andreas Spittler completed his medical studies at the University Münster/Germany and Vienna/Austria. He is an associate professor for pathophysiology and the head of the division of perioperative immunology at the department of surgery. Dr. Spittler is the head of the core facility flow cytometry. Also, Dr. Spittler is the president of the Austrian Society for Cytometry and the Austrian Society for Extracellular Vesicles. His area of work focuses on sepsis immunology with the focus on monocytes; characterization of monocytes in the early and in the late phase of sepsis; immune monitoring in critically ill patients; and extracellular vesicles. 
 Geraldine Thomas, PhD 
  Gerry Thomas is a professor of molecular pathology at Imperial College London. She is a serial biobanker, having established the Chernobyl Tissue Bank and the Wales Cancer Bank, she is now Designated Individual for the Imperial College HTA Research Licence and leads one of the largest and most varied HTA regulated Tissue Banks in the UK. She strongly believes that public involvement and information is a key part of academic research, and is actively involved in the public communication of research, particularly with respect to radiation protection, and biobanking. 
ISBER Head Office, 750 Pender Street, Suite 301, Vancouver, BC V6C 2T7, Canada.   
T: 1-604-484-5693 F: 1-604-874-4378 E: info@isber.org 


©2016 International Society for Biological and Environmental Repositories (ISBER). All rights reserved.
Facebook GooglePlus Twitter